CLINICAL TRIAL
Published on 28 Jul 2022
A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes
![A randomized triple-blind controlled clinical trial evaluation of sitagliptin in the treatment of patients with non-alcoholic fatty liver diseases without diabetes](https://www.frontiersin.org/files/myhome article library/937554/937554_Thumb_400.jpg)
doi 10.3389/fmed.2022.937554
- 3,521 views
- 9 citations